Log In

Term Description

Newborn screening dried blood spot analysis by tandem mass spectrometry (MS/MS) requires pre-processing the specimen with one of two alternative reagent methods referred to as derivatized and non-derivatized (or underivatized) methods. The methods are similar and nearly all analytes and ratios are identical with the limited number of exceptions noted in the description of the LOINC codes. Some labs choose to use the non-derivatized method because it may be faster or less expensive for their operations. There are no analytes which would be interpreted differently based on the method used to process the specimen so there is no need for different LOINC codes for the same compounds based on the reagents. In a few cases, a different LOINC code is used for the derivatized or non-derivatized tandem mass spectrometry (MS/MS) method because based on the reagents used in processing, different analytes are measured or different sets of analytes become isobaric, which means that they cannot be distinguished on the MS/MS because they have the same molecular weight after reagent processing.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
58092-8Acylcarnitine newborn screen panelC
Indent58088-6Acylcarnitine newborn screen interpretationC
Indent58093-6Acylcarnitine newborn screening comment-discussionC
Indent57084-6Fatty acid oxidation newborn screen panelC
IndentIndent46736-5Fatty acid oxidation defects newborn screen interpretationC
IndentIndent57792-4Fatty acid oxidation conditions suspected [Identifier] in DBSC
IndentIndent57709-8Fatty acid oxidation defects newborn screening comment-discussionC
IndentIndent38481-8Carnitine free (C0) [Moles/volume] in DBSCumol/L
IndentIndent53233-3Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent53234-1Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBSC{Ratio}
IndentIndent53235-8Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBSC{Ratio}
IndentIndent53236-6Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBSC{Ratio}
IndentIndent75211-3Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBSCumol/L
IndentIndent75212-1Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{ratio}
IndentIndent54462-7Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
IndentIndent75213-9Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{ratio}
IndentIndent50157-7Acetylcarnitine (C2) [Moles/volume] in DBSCumol/L
IndentIndent53166-5Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBSCumol/L
IndentIndent53167-3Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent53168-1Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
IndentIndent53169-9Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent50102-33-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBSCumol/L
IndentIndent45211-0Hexanoylcarnitine (C6) [Moles/volume] in DBSCumol/L
IndentIndent53173-13-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBSCumol/L
IndentIndent45207-8Glutarylcarnitine (C5-DC) [Moles/volume] in DBSCumol/L
IndentIndent53174-9Octenoylcarnitine (C8:1) [Moles/volume] in DBSCumol/L
IndentIndent53175-6Octanoylcarnitine (C8) [Moles/volume] in DBSCumol/L
IndentIndent53176-4Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent53177-2Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{Ratio}
IndentIndent53178-03-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
IndentIndent53402-43-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
IndentIndent53179-83-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{Ratio}
IndentIndent53180-6Decadienoylcarnitine (C10:2) [Moles/volume] in DBSCumol/L
IndentIndent45198-9Decenoylcarnitine (C10:1) [Moles/volume] in DBSCumol/L
IndentIndent45197-1Decanoylcarnitine (C10) [Moles/volume] in DBSCumol/L
IndentIndent53182-23-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBSCumol/L
IndentIndent53183-0Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBSCumol/L
IndentIndent53403-2Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
IndentIndent53184-8Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBSC{Ratio}
IndentIndent53185-5Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent53186-3Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent45200-3Dodecenoylcarnitine (C12:1) [Moles/volume] in DBSCumol/L
IndentIndent45199-7Dodecanoylcarnitine (C12) [Moles/volume] in DBSCumol/L
IndentIndent53188-93-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBSCumol/L
IndentIndent53189-73-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBSCumol/L
IndentIndent53190-5Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBSCumol/L
IndentIndent53191-3Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBSCumol/L
IndentIndent53192-1Tetradecanoylcarnitine (C14) [Moles/volume] in DBSCumol/L
IndentIndent53193-9Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent53194-7Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBSC{Ratio}
IndentIndent53195-4Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent70159-9Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBSC{ratio}
IndentIndent53196-23-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBSCumol/L
IndentIndent53197-03-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBSCumol/L
IndentIndent50281-53-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBSCumol/L
IndentIndent53198-8Palmitoleylcarnitine (C16:1) [Moles/volume] in DBSCumol/L
IndentIndent53199-6Palmitoylcarnitine (C16) [Moles/volume] in DBSCumol/L
IndentIndent50121-33-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBSCumol/L
IndentIndent50125-43-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBSCumol/L
IndentIndent53201-03-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent45217-7Linoleoylcarnitine (C18:2) [Moles/volume] in DBSCumol/L
IndentIndent53202-8Oleoylcarnitine (C18:1) [Moles/volume] in DBSCumol/L
IndentIndent53241-6Stearoylcarnitine (C18) [Moles/volume] in DBSCumol/L
IndentIndent53400-8Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
IndentIndent50109-83-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBSCumol/L
IndentIndent50113-03-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBSCumol/L
IndentIndent50132-03-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBSCumol/L
IndentIndent53836-3ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Indent57085-3Organic acid newborn screen panelC
IndentIndent46744-9Organic acidemias newborn screen interpretationC
IndentIndent57791-6Organic acidemia conditions suspected [Identifier] in DBSC
IndentIndent57708-0Organic acidemias defects newborn screening comment-discussionC
IndentIndent50157-7Acetylcarnitine (C2) [Moles/volume] in DBSCumol/L
IndentIndent53237-4Acrylylcarnitine (C3:1) [Moles/volume] in DBSCumol/L
IndentIndent53160-8Propionylcarnitine (C3) [Moles/volume] in DBSCumol/L
IndentIndent53161-6Propionylcarnitine (C3)/Methionine [Molar ratio] in DBSC{Ratio}
IndentIndent53162-4Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBSC{Ratio}
IndentIndent53163-2Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent54462-7Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
IndentIndent67708-8Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBSCumol/L
IndentIndent75213-9Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{ratio}
IndentIndent53164-0Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent53166-5Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBSCumol/L
IndentIndent53167-3Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent53168-1Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
IndentIndent53169-9Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent53170-7Tiglylcarnitine (C5:1) [Moles/volume] in DBSCumol/L
IndentIndent45207-8Glutarylcarnitine (C5-DC) [Moles/volume] in DBSCumol/L
IndentIndent75216-2Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS{ratio}
IndentIndent67701-3Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent67710-4Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBSCumol/L
IndentIndent67711-2Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent45216-9Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBSCumol/L
IndentIndent53238-2Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBSC{Ratio}
IndentIndent53239-0Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBSC{Ratio}
IndentIndent53240-8Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBSC{Ratio}
IndentIndent53401-6Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent50106-43-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBSCumol/L
IndentIndent53171-53-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBSC{Ratio}
IndentIndent53172-33-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent53178-03-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBSCumol/L
IndentIndent53402-43-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
IndentIndent53179-83-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBSC{Ratio}
IndentIndent45222-7Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBSCumol/L
IndentIndent67709-6Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBSCumol/L
IndentIndent53181-4Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBSC{Ratio}
IndentIndent53183-0Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBSCumol/L
IndentIndent53403-2Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBSC{Ratio}
IndentIndent53184-8Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBSC{Ratio}
IndentIndent53185-5Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBSC{Ratio}
IndentIndent53186-3Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBSC{Ratio}
IndentIndent53187-1Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBSCumol/L
IndentIndent53165-7Formiminoglutamate [Moles/volume] in DBSCumol/L

LOINC Names Get Info

Fully-Specified Name
Acylcarnitine newborn screen panel:-:Pt:Bld.dot:-:
Long Common Name
Acylcarnitine newborn screen panel
Short Name
Acylcarnitine NBS pnl DBS
Display Name
Acylcarnitine NBS panel (DBS)
Consumer Name Alpha Get Info
Acylcarnitine NBS Panel, Dried blood spot

Part Model Get Info

  • Component
    Acylcarnitine newborn screen panel
    LP98173-5
    • Analyte
      Acylcarnitine newborn screen panel
      LP98173-5
      • Component Numerator
        Acylcarnitine newborn screen panel
        LP98173-5
        • Component Numerator Core
          Acylcarnitine newborn screen panel
          LP98173-5
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    Bld.dot
    LP21304-8
    • System Core
      Bld.dot
      LP21304-8
    • Super System
      NULL
       
  • Scale
    -
    LP7747-1
  • Method
    NULL
     

Basic Attributes

Class
PANEL.CHEM
Type
Laboratory
First Released
Version 2.29
Last Updated
Version 2.77 (PANEL)
Order vs. Observation
Order
Common Test Rank Get Info
16130
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
54089-8Newborn screening panel American Health Information Community (AHIC)

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Acylkarnitin novorozenecký screening panel:-:Časový bod:Suchá krevní kapka (DBS):-:
el-GRGreek (Greece)Πίνακας εξετάσεων διαλογής νεογνών για ακυλοκαρνιτίνη:-:Pt:Bld.dot:-:
Synonyms: - Bld.dot CHEM PANEL.CHEM Pt Αίμα Ακυλοκαρνιτίνη Πίνακας εξετάσεων διαλογής νεογνών για ακυλοκαρνιτίνη
es-ESSpanish (Spain)Panel de cribado neonatal de acilcarnitina:Propiedades mixtas (sólo paneles):Punto temporal:gota de sangre (papel de filtro):-:
es-MXSpanish (Mexico)Panel de pantalla para recién nacidos de acilcarnitina:-:Punto temporal:DBS:-:
et-EEEstonian (Estonia)Atsüülkarnitiini sõeluuring vastsündinul:-:Pt:Vereplekk:-:
Synonyms: Juhuslik Veri
fr-FRFrench (France)Acylcarnitine dépistage néonatal panel:-:Ponctuel:Sang buvard:-:
fr-BEFrench (Belgium)Panel screening néonatal acylcarnitine:-:Temps ponctuel:Sang sur papier filtre:-:
it-ITItalian (Italy)Acilcarnitina, panel screening neonatale:-:Pt:Sangue.su carta da filtro:-:
Synonyms: Chimica Panel screening neonatale acilcarnitina Punto nel tempo (episodio) Sangue Set di prescrizione chimica Spot sangue secco
nl-NLDutch (Netherlands)acylcarnitine pasgeborene screening panel:-:moment:gedroogde bloedspot:-:
pl-PLPolish (Poland)Panel przesiewowy noworodków na acylokarnityny:-:punkt w czasie:sucha kropla krwi:-:
pt-BRPortuguese (Brazil)Acilcarnitina triagem neonatal painel:#N/A:Pt:SgPapel:-:
Synonyms: ; Acylcarnitine NBS pnl; Acylcarni; Acyl carnitine; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Scr; Scn; Scrn; Pnl; Pan; Panl; New born; PANEL.CHEMISTRY; PANEL.CHEMISTRY; Chemistry
ru-RURussian (Russian Federation)Ацилкарнитин новорождённый скрин панель:-:ТчкВрм:Кр.Сух.капл:-:
Synonyms: Кровь Кровь сухая капля Точка во времени;Момент
zh-CNChinese (China)酰基肉碱新生儿筛查组套:-:时间点:全血.斑点:-:
Synonyms: 全血斑点(滤纸);滤纸;血液.斑点;血液斑点(滤纸) 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.化学试验;化学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;化学医嘱组类;医嘱组.化学;医嘱组.化学检验项目;医嘱组类.化学;医嘱组类.化学检验项目;医嘱组类.化学试验;实验室医嘱组类.化学;实验室医嘱组类.化学检验项目;实验室医嘱组类.化学试验 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 筛查 筛查试验 筛选试验 组 组合 组合医嘱 组合类 组套 血;血液 过筛 过筛试验 酰基肉碱（肉毒碱、三甲基羟基丁酰甜菜碱、卡尼丁）;酰基肉毒碱 酰基肉碱（肉毒碱、三甲基羟基丁酰甜菜碱、卡尼丁）新生儿筛查组套;酰基肉碱新生儿筛查组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;酰基肉毒碱新生儿筛查医嘱组

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=58092-8
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/58092-8